Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04083859 · ClinicalTrials.gov registry record · NA
Digital Outreach Intervention for Lung Cancer Screening
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 26,998
- Enrollment target
NCT04083859: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT04083859 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 26,998 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1824% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04083859, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 26,998 participants
- Enrollment target
Study Summary
mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews. This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.
Primary Outcome
Participants who have completed any chest CT within 16 weeks of study randomization, as determined by electronic health record review
Interventions
- OTHER mPATH-Lung
- OTHER Lung health video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,998 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT04083859 record still lists
NCT04083859 is an interventional study that assigns participants to a tested intervention. Its 26,998 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1824% higher).
The record links to 0 conditions, and to 2 interventions - of which mPATH-Lung is the first listed.
NCT04083859 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04083859 about?
NCT04083859 is a clinical study titled "Digital Outreach Intervention for Lung Cancer Screening". mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic rand...
What is the current status of trial NCT04083859?
This trial is currently completed. It is a NA study. The enrollment target is 26,998 participants. The study started on 2022-01-01. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT04083859?
The interventions under investigation include: mPATH-Lung (OTHER), Lung health video (OTHER).
Who is sponsoring clinical trial NCT04083859?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04083859's enrollment target sits among peer trials
26,998 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI